Featured Solutions
-
Altasciences' CNS Center Of Excellence: Award-Winning Services
5/9/2025
Recognized globally as a CNS Center of Excellence, Altasciences has completed more than 200 preclinical and clinical neurological studies, in addition to providing formulation, manufacturing, and analytical testing services, as well as bioanalytical support. Speak with one of their experts!
-
Clinical Solutions For Early-Phase Drug Development
5/2/2025
Altasciences provides deep expertise in all clinical pharmacology studies required for successful regulatory submission across a wide range of therapeutic areas.
View the complete resource library.
Contact an Altasciences expert to learn more about their comprehensive clinical solution.
-
Two Regulatory Pathways — One Expert Partner
4/25/2025
Whether you’re pursuing an IND submission in the U.S. or a CTA in Canada and Europe, our integrated solutions model provides comprehensive regulatory support at every drug development stage.
-
Drug-Drug Interaction Clinical Trials
3/19/2025
We specialize in DDI studies, including stand-alone and 'cocktail' designs, assessing multiple CYP enzymes or transporters in single studies, from simple crossovers to complex adaptive trials.
-
Renal And Hepatic Impaired Studies
11/20/2024
Altasciences has successfully designed, conducted, analyzed, and reported numerous clinical trials focused on renal and hepatic impairment across a wide range of therapeutic areas.
-
Metabolic Disorders
10/8/2024
Altasciences has over 25 years of experience in metabolic diseases and supports every stage of the development process, from discovery to clinical trials — and beyond.
-
Flow Cytometry And PBMC Isolation — Powerful Tools For Your Clinical Trials
8/20/2024
Did you know? Altasciences’ clinical facilities are integrated with state-of-the-art flow cytometry laboratories. With our deep expertise in regulated cellular analysis, our team ensures that every step — from sample collection and processing to transport and analysis — is optimized for precision and speed.
-
Clinical Trial Site Selection And Management
7/25/2024
Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.
-
Clinical Pharmacology Studies For NDA Filing
6/18/2024
Need help with inclusion/exclusion criteria for your Phase 2/3 protocol or an unexpected FDA post-marketing amendment? Altasciences offers reliable solutions with a quick start-up.
-
Human Abuse Potential
4/17/2024
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.